Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-subsidiarys-drug-passing-the-consistency-evaluation-for-generic-drugs
Release
Harbin Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Harbin Pharmaceutical
- Announcement on Affiliated Enterprise Obtaining Approval for Marketing of Chemical APIs
- Announcement on Subsidiary Obtaining Drug Registration Certificate
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on the Change of Quality Control Reviewer
- Announcement on the Change of Signatory Certified Public Accountant and Quality Control Reviewer
Later from Harbin Pharmaceutical
- Announcement on Resolutions of the 24th Meeting of the 10th Board of Directors
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Change of Accounting Policies
- Announcement on Attending the Online Collective Reception Day for Investors of Listed Companies in Heilongjiang Jurisdiction in 2026 and the 2025 Annual and Q1 2026 Performance Briefing
- Notice on Convening the 2025 Annual General Meeting
Follow Harbin Pharmaceutical into a list and get an email when it puts out news.
Follow Harbin Pharmaceutical